Journal of Molecular Medicine

, Volume 82, Issue 9, pp 621–628

Stimulation of c-Rel transcriptional activity by PKA catalytic subunit β

  • Shih-Hung Yu
  • Wei-Chung Chiang
  • Hsiu-Ming Shih
  • Kou-Juey Wu
Original Article


Nuclear factor κB (NF-κB) is a eukaryotic transcription factor which responds to different extracellular signals. It is involved in immune response, inflammation, and cell proliferation. Increased expression of c-Rel (or its viral homolog v-Rel), one component of the NF-κB factors, induces tumorigenesis in different systems. The activity of NF-κB can be regulated by protein kinase A (PKA) in a cAMP-independent manner. Our previous results showed that c-MYC induces the activity of PKA by inducing the transcription of the gene encoding the PKA catalytic subunit β (PKA-Cβ). Constitutive expression of PKA-Cβ in Rat1a cells induces their transformation. Here we show that CREB is unlikely to be a phosphorylation target of PKA-Cβ as characterized by different cell lines. Electrophoretic mobility shift assays showed that c-Rel is present as a significant component of the NF-κB factors in c-MYC overexpressing status. The transcriptional activity of c-Rel was significantly stimulated by PKA-Cβ. Coactivators p300/CBP are at least partially responsible for the enhanced activation mediated by c-Rel and PKA-Cβ. Interaction between c-Rel and PKA-Cβ was demonstrated using coimmunoprecipitation assays. Immunoprecipitation-in vitro phosphorylation assays showed the direct phosphorylation of c-Rel by PKA-Cβ. These results indicate that c-Rel is a reasonable phosphorylation target of PKA-Cβ, and that the transcriptional activity of c-Rel is stimulated by PKA-Cβ possibly through the interaction with p300/CBP.


Nuclear factor kB c-Rel Protein kinase A catalytic subunit β c-MYC Transcription 



CREB-binding protein


Inhibitor factor κB


Nuclear factor κB


Protein kinase A


Sodium dodecyl sulfate polyacrylamide gel electrophoresis




  1. 1.
    Ghosh S, May MJ, Kopp EB (1998) NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16:225–260PubMedGoogle Scholar
  2. 2.
    Gerondakis S, Grumont R, Rouke I, Grossman M (1998) The regulation and roles of Rel/NF-κB transcription factors during lymphocyte activation. Curr Opin Immunol 10:353–359CrossRefPubMedGoogle Scholar
  3. 3.
    Mercurio F, Manning AM (1999) Multiple signals converging on NF-κB. Curr Opin Cell Biol 11:226–232Google Scholar
  4. 4.
    Mayo MW, Baldwin AS (2000) The transcription factor NF-κB: control of oncogenesis and cancer gene therapy. Biochim Biophys Acta 1470:M55–M62CrossRefPubMedGoogle Scholar
  5. 5.
    Rayet B, Gelinas C (1999) Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18:6938–6947CrossRefPubMedGoogle Scholar
  6. 6.
    Hsia CY, Cheng S, Owyang AM, Dowdy SF, Liou HC (2002) c-Rel regulation of the cell cycle in primary mouse B lymphocytes. Int Immunol 14:905–916CrossRefPubMedGoogle Scholar
  7. 7.
    Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin AS Jr (1999) NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 19:5785–5799PubMedGoogle Scholar
  8. 8.
    Kalaitzidis D, Davis RE, Rosenwald A, Staudt LM, Gilmore TD (2002) The human B-cell lymphoma cell line RC-K8 has multiple genetic alterations that dysregulate the Rel/NF-κB signal transduction pathway. Oncogene 21:8759–8768CrossRefPubMedGoogle Scholar
  9. 9.
    Martin-Subero JI, Gesk S, Harder L, Sonoki T, Tucker PW, Schlegelberger B, Grote W, Novo FJ, Calasanz MJ, Hansmann ML, Dyer MJ, Siebert R (2002) Recurrent involvement of the Rel and Bcl11A loci in classical Hodgkin lymphomas. Blood 99:1474–1477CrossRefPubMedGoogle Scholar
  10. 10.
    Ni H, Ergin M, Huang Q, Qin JZ, Amin HM, Martinez RL, Saeed S, Barton K, Alkan S (2001) Analysis of expression of nuclear factor kappa B (NF-κB) in multiple myeloma: downregulation of NF-kB induces apoptosis. Br J Haematol 115:279–286CrossRefPubMedGoogle Scholar
  11. 11.
    Gilmore T, Gapuzan ME, Kalaitzidis D, Starczynowski D (2002) Rel/NF-κB/I-κB signal transduction in the generation and treatment of human cancer. Cancer Lett 181:1–9CrossRefPubMedGoogle Scholar
  12. 12.
    Gilmore TD, Cormier C, Jean-Jacques J, Gapuzan ME (2001) Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel. Oncogene 20:7098–7103CrossRefPubMedGoogle Scholar
  13. 13.
    Romieu-Mourez R, Kim DW, Shin SM, Demicco EG, Landesman-Gollag E, Seldin DC, Cardiff RD, Sonenshein GE (2003) Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. Mol Cell Biol 23:5738–5754CrossRefPubMedGoogle Scholar
  14. 14.
    Dong QG, Sclabas GM, Fujioka S, Schmidt C, Peng B, Wu T, Tsao MS, Evans DB, Abbruzzese JL, McDonnell TJ, Chiao PJ (2002) The function of multiple I-κB: NF-κB complexes induce the resistance of cancer cells to taxol-induced apoptosis. Oncogene 21:6510–6519CrossRefPubMedGoogle Scholar
  15. 15.
    Zhong H, SuYang H, Erdjument-Bromage H, Tempst P, Ghosh S (1997) The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89:413–424PubMedGoogle Scholar
  16. 16.
    Zhong H, Voll RE, Ghosh S (1998) Phosphorylation of NF-κB p65 by PKA stimuates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1:661–671PubMedGoogle Scholar
  17. 17.
    Wu KJ, Mattioli M, Morse HC III, Dalla-Favera R (2002) c-MYC activates protein kinase A (PKA) by directional transcriptional activation of the PKA catalytic subunit beta (PKA-Cβ) gene. Oncogene 21:7872–7882CrossRefPubMedGoogle Scholar
  18. 18.
    Daniel PB, Walker WH, Habener JF (1998) Cyclic AMP signaling and gene regulation. Annu Rev Nutr 18:353–383CrossRefPubMedGoogle Scholar
  19. 19.
    Taylor SS, Buechler JA, Yonemoto W (1990) cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. Annu Rev Biochem 59:971–1005PubMedGoogle Scholar
  20. 20.
    Skalhegg BS, Tasken K (2000) Specificity in the cAMP/PKA signaling pathway. Differential expression, regulation, and subcellular localization of subunits of PKA. Front Biosci 5:D678–D693PubMedGoogle Scholar
  21. 21.
    Montminy M (1997) Transcriptional regulation by cyclic AMP. Annu Rev Biochem 66:807–822PubMedGoogle Scholar
  22. 22.
    Dhillon AS, Pollock C, Steen H, Shaw PE, Mischak H, Kolch W (2002) Cyclic AMP-dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259. Mol Cell Biol 22:3237–3246CrossRefPubMedGoogle Scholar
  23. 23.
    Gu W, Cechova K, Tassi V, Dalla-Favera R (1993) Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. Proc Natl Acad Sci USA 90:2935–2939PubMedGoogle Scholar
  24. 24.
    Wu KJ, Polack A, Dalla-Favera R (1999) Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. Science 283:676–679CrossRefPubMedGoogle Scholar
  25. 25.
    Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J, Dalla-Favera R (1999) Direct activation of TERT transcription by c-MYC. Nat Genet 21:220–224CrossRefPubMedGoogle Scholar
  26. 26.
    Andrews NC, Faller DV (1991) A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19:2499PubMedGoogle Scholar
  27. 27.
    Loeb DM, Tsao H, Cobb MH, Greene LA (1992) NGF and other growth factors induce an association between ERK1 and the NGF receptor, gp140 prototrk. Neuron 9:1053–1065PubMedGoogle Scholar
  28. 28.
    Martin AG, Fresno M (2000) Tumor necrosis factor-α activation of NF-κB requires the phosphorylation of Ser-471 in the transactivation domain of c-Rel. J Biol Chem 275:24383–24391CrossRefPubMedGoogle Scholar
  29. 29.
    Naumann M, Scheidereit C (1994) Activation of NF-κB in vivo is regulated by multiple phosphorylations. EMBO J 13:4597–4607PubMedGoogle Scholar
  30. 30.
    Kempkes B, Spitkovsky D, Jansen-Durr P, Ellwart JW, Kremmer E, Delecluse HJ, Rottenberger C, Bornkamm GW, Hammerschmidt W (1995) B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2. EMBO J 14:88–96PubMedGoogle Scholar
  31. 31.
    Jiang J, Struhl G (1995) Protein kinase A and hedgehog signaling in Drosophila limb development. Cell 80:563–572PubMedGoogle Scholar
  32. 32.
    Chen C, Agnes F, Gelinas C (1999) Mapping of a serine-rich domain essential for the transcriptional, antiapoptotic and transforming activities of the v-Rel oncoprotein. Mol Cell Biol 19:307–316PubMedGoogle Scholar
  33. 33.
    Rayet B, Fan Y, Gelinas C (2003) Mutations in the v-Rel transactivation domain indicate altered phosphorylation and identify a subset of NF-κB-regulated cell death inhibitors important for v-Rel transforming activity. Mol Cell Biol 23:1520–1533CrossRefPubMedGoogle Scholar
  34. 34.
    Chen C, Edelstein LC, Gelinas C (2000) The Rel/NF-κB family directly activates expression of the apoptosis inhibitor Bcl-xL. Mol Cell Biol 20:2687–2695CrossRefPubMedGoogle Scholar
  35. 35.
    Sun SC, Maggirwar SB, Harhaj EW, Uhlik M (1999) Binding of c-Rel to STAT5 target sequences in HTLV-I-transformed T cells. Oncogene 18:1401–1409CrossRefPubMedGoogle Scholar
  36. 36.
    Petrenko O, Ischenko I, Enrietto PJ (1997) Characterization of changes in gene expression associated with malignant transformation by the NF-κB family member, v-Rel. Oncogene 15:1671–1680CrossRefPubMedGoogle Scholar
  37. 37.
    Lee H, Arsura M, Wu M, Duyao M, Buckler AJ, Sonenshein GE (1995) Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. J Exp Med 181:1169–1177PubMedGoogle Scholar
  38. 38.
    Kanda K, Hu HM, Zhang L, Grandchamps J, Boxer LM (2000) NF-κB activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer. J Biol Chem 275:32338–32446CrossRefPubMedGoogle Scholar
  39. 39.
    Ji L, Arcinas M, Boxer LM (1994) NF-κB sites function as positive regulators of expression of the translocated c-myc allele in Burkitt’s lymphoma. Mol Cell Biol 14:7967–7974PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Shih-Hung Yu
    • 1
  • Wei-Chung Chiang
    • 1
  • Hsiu-Ming Shih
    • 2
  • Kou-Juey Wu
    • 1
  1. 1.Institute of BiochemistryNational Yang-Ming UniversityTaipei 112Taiwan
  2. 2.Division of Molecular and Genomic MedicineNational Health Research InstitutesTaipei 115Taiwan

Personalised recommendations